Tocilizumab in severe COVID-19 - A randomized, double-blind, placebo-controlled trial
{{output}}
Background: The therapeutic effectiveness of interleukin-6 receptor inhibitor in critically ill hospitalized patients with coronavirus disease 2019 (COVID-19) is uncertain. ... ...
